Lipid nanoparticles (LNPs) have transformed how we deliver mRNA. But their role in modern medicine is just beginning.
In this new expert-authored article, BioCina explores how LNPs are being engineered to deliver a wider range of payloads, including siRNA, gene-editing systems, peptides, and small molecules, across therapeutic areas from oncology to neurology.
In this article, learn about:
- Strategies to optimize LNP targeting, biodistribution, and stability
- Applications in gene silencing, CAR-T, chronic disease, and more
- How thermal-stable LNPs can improve global access and reduce logistics costs
- BioCina’s integrated capabilities across mRNA, pDNA, LNPs, and GMP production
Discover how a platform born for vaccines is now powering the next generation of advanced therapies.